Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
91.10
+2.36 (2.66%)
Dec 5, 2025, 4:00 PM EST - Market closed

Globus Medical Stock Forecast

Stock Price Forecast

According to 11 professional analysts, the 12-month price target for Globus Medical stock ranges from a low of $64 to a high of $115. The average analyst price target of $93.09 forecasts a 2.18% increase in the stock price over the next year.

Price Target: $93.09 (+2.18%)
Analyst Consensus: Buy
Target Low Average Median High
Price $64 $93.09 $92 $115
Change -29.75% +2.18% +0.99% +26.23%

Analyst Ratings

The average analyst rating for Globus Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jul '25Aug '25Sep '25Oct '25Nov '25Dec '25
Strong Buy 333355
Buy 555555
Hold 555644
Sell 000000
Strong Sell 000000
Total 131313141414

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Morgan Stanley
Morgan Stanley
Buy
Maintains
$70$100
Buy Maintains $70$100 +9.77% Dec 2, 2025
Truist Securities
Truist Securities
Strong Buy
Reiterates
$93$105
Strong Buy Reiterates $93$105 +15.26% Nov 18, 2025
Barclays
Barclays
Buy
Maintains
$106$114
Buy Maintains $106$114 +25.14% Nov 10, 2025
RBC Capital
RBC Capital
Buy
Maintains
$88$92
Buy Maintains $88$92 +0.99% Nov 7, 2025
Wells Fargo
Wells Fargo
Buy
Maintains
$66$79
Buy Maintains $66$79 -13.28% Nov 7, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
2.94B
from 2.52B
Increased by 16.66%
Revenue Next Year
3.18B
from 2.94B
Increased by 8.27%
EPS This Year
3.87
from 0.75
Increased by 415.81%
EPS Next Year
4.20
from 3.87
Increased by 8.59%
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
789.04M958.10M1.02B1.57B2.52B2.94B3.18B
Revenue Growth
0.47%21.43%6.76%53.35%60.62%16.66%8.27%
EPS
1.011.441.851.070.753.874.20
EPS Growth
-33.55%42.57%28.47%-42.16%-29.91%415.81%8.59%
Forward PE
-----23.5521.69
No. Analysts
-----1616
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 2025202620272028
High 3.0B 3.3B
Avg 2.9B 3.2B
Low 2.8B 3.0B

Revenue Growth

Revenue Growth 2025202620272028
High
20.9%
12.8%
Avg
16.7%
8.3%
Low
10.7%
2.2%

EPS Forecast

EPS 2025202620272028
High 4.00 4.52
Avg 3.87 4.20
Low 3.68 3.77

EPS Growth

EPS Growth 2025202620272028
High
433.4%
16.8%
Avg
415.8%
8.6%
Low
391.3%
-2.5%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.